Top Health Tech Companies in Singapore (130)
InterSystems builds the software that makes complex systems work—reliably, securely, and at scale. For more than 45 years, we’ve been the information engine behind some of the world’s most mission-critical applications in healthcare, government, and business. Our data management, integration, and analytics technologies help organizations connect disparate systems, turn data into insight, and deliver better outcomes. From enabling interoperable healthcare and...
InterSystems's Top Stability & Growth Strengths
Resilient & Sustainable Growth: Growth is described as measured and predictable, with signals such as modest headcount expansion, sustained operating scale, and continued momentum rather than volatility.
Innovation-Driven Growth: Recent major releases across IRIS/IRIS for Health/Health Connect and new AI-focused offerings indicate ongoing R&D velocity that broadens capabilities and use cases.
Strong Market Position & Advantage: Repeated industry accolades for Shared Care Records/HIE and regional acute EHRs in 2026 point to durable competitive standing in core healthcare markets.
ZS is a management consulting and technology firm that partners with companies to improve life and how we live it. We transform ideas into impact by bringing together data, science, technology and human ingenuity to deliver better outcomes for all. Founded in 1983, ZS has more than 15,000+ employees in over 40 offices worldwide.
ZS's Top Stability & Growth Strengths
Market Expansion: Headcount and footprint are described as rising to more than 15,000 employees across 40-plus offices, alongside concrete new sites in Hyderabad and a completed Chicago buildout—signals of geographic and capacity expansion. These moves indicate confidence in demand across key delivery hubs.
Innovation-Driven Growth: A dedicated Platforms & Products unit, the ZAIDYN portfolio, and AI-agent initiatives point to sustained investment in productized, AI-enabled offerings. Capability-deepening acquisitions (Digital Additive in 2024 and Torrent Consulting in 2025) further strengthen CRM and multi‑cloud life‑sciences solutions.
Strategic Partnerships: An expanded Salesforce collaboration around Agentforce and recognition as Databricks 2025 Life Sciences Partner of the Year suggest momentum in data/AI ecosystems. These alliances position the firm to capture spend where CRM, data, and AI converge in healthcare and life sciences.
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of health care. Our portfolio of devices and therapies helps...
Boston Scientific's Top Stability & Growth Strengths
Strong Revenue Growth: Full-year 2025 results show strong double-digit expansion in net sales alongside higher adjusted EPS, indicating robust top-line momentum. The 2026 outlook still points to continued year-over-year expansion, even if at a slower pace than 2025.
Strong Market Position & Advantage: Category leadership is highlighted in structural heart (WATCHMAN LAAC) and a front-runner position in pulsed-field ablation (FARAPULSE), supporting durable competitive advantage in key cardiovascular niches. Scale is reinforced by top-tier global medtech revenue positioning and broad strength across interventional cardiology, vascular therapies, and select MedSurg areas.
Innovation-Driven Growth: Recent approvals and launches (e.g., focal PFA catheter and IVL offerings) and ongoing clinical programs are positioned as sustaining procedure growth and share gains. Targeted M&A (e.g., Axonics and Silk Road Medical) is framed as extending participation in faster-growing categories and reinforcing category-leadership strategy.
Anne Carlsen is a North Dakota nonprofit serving children, young adults, and families affected by developmental disabilities or delays. Its person-centered programs include residential care, therapy, early intervention, education, behavioral health, community support, recreation, and assistive technology. Guided by a mission to make independence a gift for all, the organization combines specialized services, creative therapies, and technology to foster dignity,...
Epic AI Systems specializes in AI automation for businesses, with a primary focus on clinics and medical practices. The company leverages AI chatbots, agents, and virtual assistants to help healthcare providers boost patient acquisition, increase retention, and improve overall operational efficiency. Their goal is to enhance the patient experience and streamline business processes through the application of intelligent AI automation.
Medtronic is a global healthcare solutions company operating in approximately 160 countries. We are committed to improving lives through our medical technologies, services, and solutions. Since our beginning, 60 years ago, our Mission has remained the same: to alleviate pain, restore health, and extend life for people around the world. The Mission is our ethical framework and inspirational goal guiding...
Medtronic's Top Stability & Growth Strengths
Strong Revenue Growth: Revenue accelerated to the fastest annual pace in a decade in FY2026, with momentum evident into the fourth quarter. Management’s outlook points to continued upper single‑digit organic expansion in the coming year.
Healthy Cash Flow: Strong free cash flow and a long-running pattern of dividend increases indicate durable cash generation. Recent dividend actions and ongoing cash returns underscore capacity to fund investment and tuck‑in M&A.
Strong Market Position & Advantage: Scale leadership at the top of global medtech by revenue, with breadth across Cardiovascular, Neuroscience, and Medical Surgical, supports resilience. Category strength in areas like cardiac pacing and ablation provides commercial leverage for new launches.
Opto GmbH is an expanding company specializing in optics, camera technology, and software, with a focus on photonics and industrial image processing. The company develops and manufactures high-precision, AI-ready digital microscopes and vision sensors as imaging and job modules for medical technology and industrial applications. It serves as a trusted partner for machine builders and system integrators, delivering tailored solutions...
For over 240 years, Takeda’s propensity to evolve has driven the next generation of innovation, and as a future-focused organization, we’re continuing to drive forward with endurance in our steadfast pursuit to achieve the best outcomes for our patients in a rapidly changing world. We have been preparing for this period of value creation by investing in data, digital and...
Takeda's Top Stability & Growth Strengths
Strong Market Position & Advantage: Takeda is consistently placed among the global top 15–20 by revenue and is a clear category leader in GI/IBD, plasma-derived therapies, and dengue vaccines with broad international authorizations and WHO support. Subcutaneous ENTYVIO and new oncology approvals like FRUZAQLA broaden real‑world use and extend reach.
Profitability: Reported FY2025 operating profit rose 19.3% year over year and EPS nearly doubled despite a slight revenue decline, supported by lower amortization and restructuring expense. Core profitability remained broadly stable as Growth & Launch Products expanded their share.
Future-Ready Strategy: Management is investing through FY2026 to convert a late‑stage pipeline (e.g., oveporexton, rusfertide, zasocitinib) into multiple launches, with Growth & Launch Products prioritized as near‑term engines. A multi‑year transformation and efficiency program targeting significant savings by FY2028 is intended to fund launches and strengthen competitiveness.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, and deliver better care. Because informed decisions lead to better outcomes, Elsevier is a leader in information and analytics for customers across the global research and health ecosystems. Elsevier helps researchers and healthcare professionals advance science and improve...
Elsevier's Top Stability & Growth Strengths
Strong Market Position & Advantage: Elsevier is widely regarded as a dominant force in STM publishing with flagship journals (e.g., The Lancet, Cell) and critical platforms like ScienceDirect and Scopus. Feedback suggests this entrenched position supports stable demand and reinforces its central role in research and clinical workflows.
Profitability: The business delivers strong profits with high operating margins and contributes materially to its parent company’s earnings. Feedback suggests profitability has remained robust alongside increased article output and heavy platform usage.
Innovation-Driven Growth: The company is shifting toward higher-growth analytics and AI-enabled tools and expanding through targeted healthcare tech acquisitions. Feedback suggests rapid growth in open access output and new AI-assisted research tools positions the business well for future demand.
Genesis MedTech Group is a medical device company headquartered in Singapore. Founded by a group of professionals and entrepreneurs with MedTech experience globally and in Asia, the company's product portfolio focuses on value segment multi-therapy medical device products for emerging markets with sales and distribution through its established commercial network. Genesis MedTech Group covers the entire industry value chain of...
4baseCare, an Illumina-backed Company* headquartered in Singapore, is engaged in developing cutting-edge Precision Oncology Solutions using Advanced Genomics and Next-Gen digital health technology. Taking into consideration that the clinical outcome could significantly vary across different populations, we have developed a unique set of indigenous comprehensive cancer gene panels that enables oncologists to choose the optimal precision therapies for their patients. Our...
Amplify Health is a leading health technology and analytics organisation providing payors and healthcare providers with technology platforms, data science and digital health solutions to improve outcomes for individuals and the sustainability of healthcare systems
At Olympus, we put a lot of good back into the world, and what we do, really matters. We are committed to making people’s lives healthier, safer and more fulfilling every day by crafting innovative optical and digital solutions in medical technologies; life sciences; industrial solutions; and cameras and audio products. Everything we do at Olympus is a reflection of...
At Doctor Anywhere, we are guided by the core belief that healthcare should be simple, accessible and efficient for everyone. Since our launch in 2017, we've been disrupting the healthcare industry by developing innovative solutions to bridge gaps in the healthcare ecosystem. Our services integrate both digital and offline platforms to empower users to take charge of their health. Headquartered...
MANEUVER is one of Singapore’s fastest growing companies. We build, operate and scale hyper-growth health and wellness e-commerce brands. Our goal is to elevate quality of life with functional supplements. We aim to be a dominant force and make a dent in this industry in the coming years by disrupting the traditional ways health and wellness brands are built. We...
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need.
AbbVie's Top Stability & Growth Strengths
Strong Revenue Growth: Revenue reached a record ~$61.2B in 2025 and increased 10.2% year over year in Q2 2026, with adjusted EPS up 22.9%. Immunology and Neuroscience delivered double‑digit gains, led by Skyrizi and Rinvoq each growing about 24% in Q2 2026.
Strong Market Position & Advantage: AbbVie sits in the global top tier by sales and is a category leader in immunology and medical aesthetics. Skyrizi and Rinvoq are described as pace‑setters gaining share, while Allergan Aesthetics maintains leadership with Botox and fillers.
Diversified Revenue Streams: Multiple franchises contribute meaningfully—immunology, neuroscience (e.g., Vraylar, CGRPs), and aesthetics—supported by oncology additions like ELAHERE. Recent deals (Cerevel, ImmunoGen) and a broad late‑stage pipeline across oncology, neuroscience, and eye care expand the base.
HealthBeats® is a global Remote Vitals Monitoring platform designed to bring healthcare home. We provide users with medical devices to be self-administered regularly at home and have their results transmitted real-time to their health providers for proactive care management for better health outcomes. HealthBeats™ uses multiple devices across multiple brands to meet the needs of its users and is the...
As one of the best weight loss programs in Singapore today, Eureka Wellness promises sustainable results that go beyond losing numbers on the weighing scale. We use our deep understanding of body composition to create an effective weight loss program that will burn through your harmful fat storage in weeks. Not only that, but we also empower people with the right...
Multidimensional Health Intelligence Platform for digital powered care delivery Mesh Bio is a fast growing digital health startup focused on addressing the growing challenges in care delivery. Mesh Bio develops AI powered clinical decision support, analytics and automation solutions for healthcare providers to transform healthcare delivery with digital solutions. At Mesh Bio, we actively build an environment for personal excellence...
Founded in 2017, Speedoc is a virtual clinic and healthcare solutions platform that allows users to seek medical care and services from home. As a virtual clinic and hospital care provider combining physical-digital services to challenge the traditional centralized, facility-based model, Speedoc believes that this will be the solution for the aging population faced by many countries in the region...
